Tilray Brands Inc TLRY

Alternate Symbol(s): T.TLRY

Healthcare Cannabis

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

NDAQ:TLRY - Post by User

Tilray Brands Inc > It Should Be Illegal

<< Previous

Bullboard Posts

Next >>

Comment by BudFoxx2020on Nov 18, 2021 3:28pm

213 Views

Post# 34142416

RE:It Should Be Illegal

I guarantee if Barclay said Tilray is a strong buy with a price target of $100. Everyone will be singing their praise. Lol. Got to love the markets. People just cant take things for what it is. The whole sector shot up almost 20% last week on nothing but speculation about some new cannibus legislation. Today has nothing to do with Barclay. Geez are people that dense. READ THIS AGAIN.

Democratic divide puts congressional action on marijuana in doubt

November 18, 2021
AggregatedNews
Policy & Legal
0 Comments

A split on Capitol Hill over marijuana policy has lawmakers confronting the possibility that they could again fail to pass any meaningful changes to the federal prohibition of cannabis this Congress, even as polls show vast majorities of Americans support at least partial legalization of the drug.

The clash, on one level, follows familiar contours for Washington policymaking: A narrower measure with significant bipartisan support — one that would make it easier for banks to do business with legitimate cannabis firms in states where marijuana is legal — is in limbo while a smaller group of lawmakers pushes for a much broader bill.

But it has also become infused with questions of racial equity and political competence that have pitted key Democrats against each other as they seek a way to roll back federal marijuana laws that have gone largely unchanged since the height of the War on Drugs in the 1980s and 1990s.

The conflict has come to a head in recent weeks after a push by Democratic and Republican lawmakers to attach the narrower banking legislation to the must-pass annual defense policy bill, which would ensure its passage in the coming months. The bill’s advocates say it would offer a substantial step toward legitimizing and rationalizing the cannabis industry in the 47 states that have moved to at least partially legalize marijuana — allowing businesses to move away from risky cash-only operations. [Read more at The Washington Post]